Prelude Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Baker Bros. Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 10M | 1.44 |
| 2025-06-30 | $8.2M | 10M | 0.81 |
| 2025-03-31 | $7.8M | 10M | 0.77 |
| 2024-12-31 | $13M | 10M | 1.28 |
| 2024-09-30 | $21M | 10M | 2.07 |
| 2024-06-30 | $39M | 10M | 3.81 |
| 2024-03-31 | $48M | 10M | 4.74 |
| 2023-12-31 | $43M | 10M | 4.27 |
| 2023-09-30 | $31M | 10M | 3.09 |
| 2023-06-30 | $46M | 10M | 4.50 |
| 2023-03-31 | $58M | 10M | 5.70 |
| 2022-12-31 | $61M | 10M | 6.04 |
| 2022-09-30 | $67M | 10M | 6.61 |
| 2022-06-30 | $53M | 10M | 5.22 |
| 2022-03-31 | $70M | 10M | 6.90 |
| 2021-12-31 | $126M | 10M | 12.45 |
| 2021-09-30 | $316M | 10M | 31.25 |
| 2021-06-30 | $290M | 10M | 28.63 |
| 2021-03-31 | $439M | 10M | 43.33 |
| 2020-12-31 | $724M | 10M | 71.55 |
| 2020-09-30 | $305M | 10M | 30.13 |